The underlying mechanisms may be explained by in vitro studies of HepG2 hepatocellular carcinoma cells that demonstrated an IL-22-mediated induction of various anti-apoptotic and mitogenic proteins [35]. The gene discussed is IL22; the disease is hepatocellular carcinoma.